Fundraising Fox

Coherus Biosciences

NASDAQ: CHRS

Redwood City, US · Founded 2010 · Delaware corporation · 3 known investors

coherus.com ↗

Coherus Oncology develops and commercializes immuno-oncology therapies, including the approved LOQTORZI, to treat patients with cancer. The company focuses on expanding its pipeline of clinical-stage candidates targeting the tumor microenvironment.

BiotechHealthtechMedical Devicesin /coherus-oncology@coherus_bio

Founders & leadership

BK
Barbara K Finck, M.D.Executive Officer
AJ
Ali J. SatvatDirector
MW
Mats WahlstromDirector
AC
Alan C. HermanExecutive Officer
DM
Dennis M. LanfearExecutive Officer, Director
JV
Jean-Frederic Viret, Ph.D.Executive Officer
CR
Christos RichardsDirector
MT
Mary T. SzelaDirector
AJ
August J. Troendle, M.D.Director
VB
V. Bryan Lawlis, Ph.D.Director
PK
Peter K. Watler, Ph.D.Executive Officer
JI
James I. Healy, M.D., Ph.D.Director

Investors · 3

F-Prime Capital PartnersCambridge · $3M – $10M
HEALTHCARE ROYALTY PARTNERSNew York
Sofinnova VenturesMenlo Park · $100K – $15M

Reported raises · per SEC filings

Form D private placements
▶$6.8MraisedDec 2017 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • V. Bryan LawlisDirector
  • Mats WahlstromDirector
  • Dennis M. LanfearExecutive Officer, Director
  • Barbara K. Finck, M.D.Executive Officer
  • Peter K. Watler, Ph.D.Executive Officer
  • August J. Troendle, M.D.Director
  • Alan C. HermanExecutive Officer
  • Jean Frederic Viret, Ph.D.Executive Officer
  • James I. Healy, M.D., Ph.D.Director
  • Christos RichardsDirector
  • Mary T. SzelaDirector
  • Ali J. SatvatDirector
Offering amount
$6.8M
Amount sold
$6.8M
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedSep 2015 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Barbara K Finck, M.D.Executive Officer
  • Ali J. SatvatDirector
  • Mats WahlstromDirector
  • Alan C. HermanExecutive Officer
  • Dennis M. LanfearExecutive Officer, Director
  • Jean-Frederic Viret, Ph.D.Executive Officer
  • Christos RichardsDirector
  • Mary T. SzelaDirector
  • August J. Troendle, M.D.Director
  • V. Bryan Lawlis, Ph.D.Director
  • Peter K. Watler, Ph.D.Executive Officer
  • James I. Healy, M.D., Ph.D.Director
Offering amount
$10M
Amount sold
$10M
First sale
Sep 2015
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news